143 related articles for article (PubMed ID: 6125434)
1. Intravaginal administration of 9-deoxo-9-methylene-16,16-dimethyl PGE2 for cervical dilation prior to suction curettage.
Shapiro AG; Lasseter K; Cobiella A; Domenzain M
Int J Gynaecol Obstet; 1982 Apr; 20(2):137-40. PubMed ID: 6125434
[TBL] [Abstract][Full Text] [Related]
2. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
Borten M; DiLeo LA; Friedman EA
Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
[TBL] [Abstract][Full Text] [Related]
3. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
Brenner PF; Marrs RP; Roy S; Mishell DR
Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
[TBL] [Abstract][Full Text] [Related]
4. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
Bygdeman M; Christensen N; Gréen K; Lundström V
Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
[TBL] [Abstract][Full Text] [Related]
5. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
Ballard CA
Contraception; 1981 Aug; 24(2):151-7. PubMed ID: 7297067
[TBL] [Abstract][Full Text] [Related]
6. A comparison of two stable prostaglandin E analogues for termination of early pregnancy and for cervical dilatation.
Bygdeman M; Bremme K; Christensen N; Lundström V; Gréen K
Contraception; 1980 Nov; 22(5):471-83. PubMed ID: 7471738
[TBL] [Abstract][Full Text] [Related]
7. Pre-abortion treatment with a single vaginal suppository containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 in late first and early second trimester pregnancies.
Moberg PJ; Bygdeman M; Carnsjö LG; Frankman O; Gréen K
Acta Obstet Gynecol Scand Suppl; 1983; 113():137-40. PubMed ID: 6574668
[TBL] [Abstract][Full Text] [Related]
8. Preabortion cervical dilatation with a low-dose prostaglandin suppository. A comparison of two analogs.
Lauersen NH; Graves ZR
J Reprod Med; 1984 Feb; 29(2):133-5. PubMed ID: 6708030
[TBL] [Abstract][Full Text] [Related]
9. [Preoperative dilatation of the cervix uteri by vaginal application of 9-deoxo-16, 16-dimethyl-9-methylene PGE2 in pregnancy interruption during the 1st trimester. Double-blind clinical study].
Friedli A; De Grandi P
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):215-21. PubMed ID: 3522723
[TBL] [Abstract][Full Text] [Related]
10. Controlled study of 16,16-dimethyl-trans-delta 2 prostaglandin E1 methyl ester vaginal pessaries prior to suction termination of first trimester pregnancies.
Fisher PR; Taylor JH
Br J Obstet Gynaecol; 1984 Nov; 91(11):1141-4. PubMed ID: 6388625
[TBL] [Abstract][Full Text] [Related]
11. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
Lauersen NH; Wilson KH
Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
[TBL] [Abstract][Full Text] [Related]
12. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
Wagatsuma T; Tabuchi T; Tabei T; Kaku R
Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
[TBL] [Abstract][Full Text] [Related]
13. Effects of prostaglandin E2 analogue suppository on blood loss in suction abortion.
Sidhu MS; Kent DR
Obstet Gynecol; 1984 Jul; 64(1):128-30. PubMed ID: 6738937
[TBL] [Abstract][Full Text] [Related]
14. The use of 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. A comparative study.
Smith SK; Baird DT
Br J Obstet Gynaecol; 1980 Aug; 87(8):712-7. PubMed ID: 7426533
[TBL] [Abstract][Full Text] [Related]
15. Cervical dilatation with meteneprost vaginal suppositories in first trimester abortion.
Somell C; Olund A
Contraception; 1986 Feb; 33(2):189-94. PubMed ID: 3698595
[TBL] [Abstract][Full Text] [Related]
16. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
Scher J; Jeng DY; Kerenyi TD
Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
[TBL] [Abstract][Full Text] [Related]
17. Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination.
Gréen K; Bygdeman M; Swahn ML; Vesterqvist O; Christensen NJ
Prostaglandins Leukot Essent Fatty Acids; 1988 Aug; 33(2):121-7. PubMed ID: 3174718
[TBL] [Abstract][Full Text] [Related]
18. [Cervical dilatation by use of a vaginal suppository of meteneprost before voluntary interruption of the pregnancy in the first trimester].
Maria B; André-David F; Oury JF; Stampf F; Bresson E; Rosenberg P
J Gynecol Obstet Biol Reprod (Paris); 1987; 16(5):637-42. PubMed ID: 3668189
[TBL] [Abstract][Full Text] [Related]
19. A Gemeprost vaginal suppository for cervical priming prior to termination of first trimester pregnancy.
Kajanoja P; Mandelin M; Mäkilä UM; Ylikorkala O; Felding C; Somell C; Olund A; Pedersen H
Contraception; 1984 Mar; 29(3):251-60. PubMed ID: 6539662
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different prostaglandin analogues and laminaria for preoperative dilatation of the cervix in late first trimester abortion.
Christensen NJ; Bygdeman M; Gréen K
Contraception; 1983 Jan; 27(1):51-61. PubMed ID: 6839758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]